Cancer Research UK funds ground-breaking work into many aspects of cancer. Our researchers across the UK are investigating how best to prevent, diagnose and treat different forms of the disease. They are helping to improve the quality of life for people with cancer.
A donation of £50
buys a microscope lens, meaning our scientists can focus on the small details that could help us beat cancer.
A donation of £130
funds one of our cancer nurses and their amazing work with people affected by cancer for one day.
A donation of £270
buys an exome sequencing experiment to find out in-depth information about our
DNA, so our scientists can find cancer-causing mutations.
Did you know that 81p in every pound you raise goes directly towards Cancer Research UK’s work
to beat cancer? Here are some examples of how your contribution – big or small –
can help:
£10 could buy 300 glass slides for studying cells and tumour samples in
detail under the microscope.
£30 could buy around 250 plastic Petri dishes. They’re an essential resource
for thousands of scientists who are working hard to understand cancer.
£54 could buy 22 thermometers (range -10°C to 110°C) – indispensable for
many experiments that need to be performed at very precise temperatures.
£94 could cover the cost for one woman to take part in a clinical trial
aiming to improve survival for post-menopausal women with early-stage breast
cancer.
£123 could fund one cancer information nurse for a day. Our experienced
cancer information nurses provide a confidential service for anyone with
concerns about cancer.
£260 could buy a sophisticated microarray; a powerful piece of technology,
helping scientists to scrutinise thousands of genes in a single experiment, and
identify which are switched on in cancer.
£677 could cover the cost of one person taking part in a clinical trial testing chemotherapy before and after surgery, and the antibody drug Vectibix, to improve survival for bowel cancer patients.
£1,000 could cover around 22 days running expenses for an important lab
project into a type of children’s cancer called rhabdomyosarcoma. The study aims
to identify molecules that are involved in driving tumour growth, and this could
lead to improved treatments so that more children survive the disease in the
future.